Partner Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Zhifei Commits To Acquiring $2.93bn Of

When top corporate officials began cold-calling federal agencies during the March 2020 pandemic lockdown to see how Eastman Kodak Co. , which manufactures chemicals, could help reduce expected shorta

Venture capital investment in biopharmaceutical companies is booming in 2020. And while novel cancer and immuno-oncology programs continue to attract large sums, drug developers working on treatments

Former BARDA Director Rick Bright alleged in a whistleblower complaint that other Trump administration officials wanted widespread distribution of the anti-malarial hydroxychloroquine as a potential c